On the contrary, one report showed that MEK1/2 signaling is suppressive for osteoprogenitor differentiation in a neurofibromatosis type I mouse model [47], indicating that inhibition of MEK1/2 signaling is required for osteogenic differentiation. Here, MAP2K1 is linked to neurofibromatosis type 1.